2026年05月

The Essential Thrombocythemia Market Size in the 7MM is expected to grow from USD 431 million in 2025 to USD 1,456 million in 2034.The Essential Thrombocythemia Market is projected to grow at a CAGR of 14.5% by 2034 in leading countries like the US, EU4, ... もっと読む

In an era of escalating healthcare costs and increasing pressure to demonstrate value, payers have become more sophisticated and selective in their coverage decisions, demanding rigorous evidence that extends far beyond clinical efficacy. DelveInsight rec ... もっと読む

Real-world evidence (RWE) has transformed the pharmaceutical and healthcare landscape, becoming indispensable for regulatory decisions, market access, and clinical practice optimization. DelveInsight understands that as randomized controlled trials face l ... もっと読む

In today's complex pharmaceutical landscape, securing optimal pricing and reimbursement for innovative therapies requires sophisticated analytical frameworks and strategic evidence generation. DelveInsight recognizes that Health Economics and Outcomes Res ... もっと読む

The rare disease pharmaceutical landscape presents unique challenges that demand sophisticated economic evaluation approaches. Health Economics and Outcomes Research (HEOR) has emerged as a critical framework for navigating the complexities of rare diseas ... もっと読む

↑このページのトップヘ